Our Products
Our Complete range of products are TIOGUANINE 40 MG CAPSULES, IMATINIB CAPSULES 100 & 400 MG, Temoz Capsules, TEMOZOLOMIDE CAPSULES 20 and CYENDIV NINTEDANIB CAPSULES.
Tioguanine 40 mg Capsules is one of a large series of purine analogues which interfere with nucleic acid biosynthesis, and has been found active against selected human neoplastic diseases such as Acute Non lymphocytic Leukemias and thioguanine is one of several agents with activity in the treatment of the chronic phase of chronic myelogenous leukemia.
India has many manufacturers who manufacture Tioguanine 40 mg Capsules .To know more contact us.
3s corporation is Supplier, Exporter , Wholesaler for Tioguanine 40 mg Capsules in India.
ADDITIONAL INFORMATION
Store Tioguanine 40 mg Capsules at 15° to 25°C (59° to 77°F) in a dry place.
SIDE EFFECTS
Get emergency medical help if patient has any of these signs of an allergic reaction:
hives;
difficulty breathing;
swelling of your face, lips, tongue, or throat.
Stop using thioguanine and call doctor at once if patient has any of these serious side effects:
Imatinib interferes with the growth of some cancer cells. Imatib Imatinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML). It is also used to treat certain tumors of the stomach and digestive system. Imatinib may also be used for other purposes not listed in this medication guide.
There are many generic manufacturers in India who manufacture Imatinib Capsules 100 & 400 mg including Cipla etc.
3s corporation is Supplier, Exporter , Wholesaler for Imatinib Capsules 100 & 400 mg in India.
ADDITIONAL INFORMATION
Patient should take Imatinib capsule with a meal. This will help protect Patient from stomach problems , Swallow the capsules whole with a large glass of water. Do not open or crush the capsules unless you have difficulty in swallowing (e.g. in children). − If Patient is unable to swallow the capsules, Patient can open them and pour the powder into a glass of still water or apple juice. − If Patient is a woman who is pregnant or might get pregnant and are trying to open the capsules, Patient should handle the contents with caution in order to avoid skin-eye contact or inhalation. Patient should wash her hands immediately after opening the capsules.
SIDE EFFECTS
Very common or common side effects: −
Rapid weight gain – Imatinib may cause your body to retain water (severe fluid retention).
− Signs of infection such as fever, severe chills, sore throat or mouth ulcers- Imatinib can reduce the number of white blood cells.
− Unexpected bleeding or bruising.
Uncommon or rare side effects: −
Chest pain, irregular heart rhythm (signs of heart problems).
− Cough, having difficulty breathing or painful breathing (signs of lung problems).
− Feeling light-headed, dizzy or fainting (signs of low blood pressure).
− Feeling sick (nausea), with loss of appetite, dark-coloured urine, yellow skin or eyes (signs of liver problems).
− Rash, red skin with blisters on the lips, eyes, skin or mouth, peeling skin, fever, raised red or purple skin patches, itching, burning sensation, pustular eruption (signs of skin problems).
− Severe abdominal pain, blood in your vomit, stools or urine, black stools (signs of gastrointestinal disorders).
− Severely decreased urine output, feeling thirsty (signs of kidney problems).
− Feeling sick (nausea) with diarrhoea and vomiting, abdominal pain or fever (signs of bowel problems).
− Severe headache, weakness or paralysis of limbs or face, difficulty speaking, sudden loss of consciousness (signs of nervous system problems, such as bleeding or swelling in skull/brain).
− Pale skin, feeling tired and breathlessness and having dark urine (signs of low levels of red blood cells).
− Eye pain or deterioration in vision.
− Pain in hips or difficulty walking.
− Numb or cold toes and fingers (signs of Raynaud’s syndrome).
− Sudden swelling and redness of the skin (signs of a skin infection called cellulitis).
− Difficulty hearing.
− Muscle weakness and spasms with an abnormal heart rhythm (signs of changes in the amount of potassium in your blood).
− Bruising.
− Stomach pain with feeling sick (nausea).
− Muscle spasms with a fever, red-brown urine, pain or weakness in your muscles (signs of muscle problems).
− Pelvic pain sometimes with nausea and vomiting, with unexpected vaginal bleeding, feeling dizzy or fainting due to low blood pressure (signs of problems with ovaries or womb).
− Headache or feeling tired.
− Feeling sick (nausea), being sick (vomiting), diarrhoea or indigestion.
− Rash.
− Muscle cramps or joint, muscle or bone pain.
− Swelling such as round your ankles or puffy eyes.
− Weight gain.
We are involved in offering Temoz Capsules. The capsules we make available are formulated using quality-tested chemical compounds. We take spacila care about the packaging of the formulation before the final dispatch.
Description :
Additional Information : Temozolomide is normally taken once a day for 5 days followed by a rest period of 23 days. This 28-day cycle is repeated until treatment is complete, as assessed by your doctor.
Side Effects :
Call doctor at once if patient have a serious side effect such as :
Temozolomide belongs to the group of cancer-fighting medications known asantineoplastics, and specifically to the group of antineoplastics known as alkylating agents. Temozolomide Capsules 20 & 100 mg is used for treatment of Newly Diagnosed Glioblastoma Multiforme concomitantly with radiotherapy and then as maintenance treatment.Temozolomide Capsules 20 & 100 mg is also indicated for the treatment of adult patients with refractory anaplastic astrocytoma.
India has many manufacturers who manufacture Temozolomide Capsules 20 & 100 mg .To know more contact us.
3s corporation is Supplier, Exporter , Wholesaler for Temozolomide Capsules 20 & 100 mg in India.
ADDITIONAL INFORMATION
Temozolomide is normally taken once a day for 5 days followed by a rest period of 23 days. This 28-day cycle is repeated until treatment is complete, as assessed by your doctor.
SIDE EFFECTS
Get emergency medical help if you have any of these signs of an allergic reaction:
hives;
difficult breathing;
swelling of your face, lips, tongue, or throat.
Call doctor at once if patient have a serious side effect such as:
Cyendiv (Nintedanib) is is an anti-cancer, a Soft Gelatin Capsule, used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer. It blocks the action of the abnormal protein which signals cancer cells to multiply and thereby prevents spread of cancer cells.
SIDE EFFECTS
Common side effects are Nausea, Abdominal pain, Abnormal liver function tests, Decreased appetite, diarrhea, headache, vomiting, weight loss
Lenalid belongs to a class of medicines called immunomodulatory agents. It strengthens immune responses to prevent inflammation in the body. The medicine contains enalidomide and is used for treating myelodysplastic syndrome. This syndrome is basically a group of symptoms in which the bone marrow produces abnormal blood cells and insufficient health red blood cells; and is caused due to a abnormal chromosome in the human body. Our medicine is also suitable for treating anemia and, along with dexamethasone, for the treatment of multiple myeloma. The medicine works by destroying abnormal cells in bone marrow and facilitating the formation of normal red blood cells.
Supplied as:Available in as 5 mg, 10 mg, 15 mg & 25 mg capsules
Precautions and warningsPatients with a history of kidney problems, blood clots and strokes; must consult doctor before using the medicine
The medicine may decrease the content of blood cells in the blood. The adverse effect is exhibited through various symptoms like bleeding gum, fever, throat infections and chills. If taken for treatment of myeloma, it is suggested that the patient takes some other medicines for controlling side effects like blood clot in the leg, chest pain, cough, redness and uneasy breathing pattern.
Pregnant women must consult their doctors before using the medicine. At least two reliable forms of birth control, starting 4 weeks before the patient starts taking Lenalid and ending 4 weeks. Any woman who has not had a hysterectomy (surgery to remove your uterus and/or both ovaries) or has not been in menopause for at least 24 months in a row, must agree in writing to use birth control before, during, and after taking Lenalid. Even women with fertility problems are suggested to use birth control while taking Lenalid. The patient must also have a negative pregnancy test 10 to 14 days before treatment and again at 24 hours before the treatment begins.
Lenalidomide Capsules 5, 10, 15 & 25 mg (lenalidomide), a thalidomide analogue, is an immunomodulatory agent with antiangiogenic and antineoplastic properties.Lenalidomide inhibited the secretion of pro-inflammatory cytokines and increased the secretion of antiinflammatory cytokines from peripheral blood mononuclear cells. Lenalidomide inhibited cell proliferation with varying effectiveness (IC50s) in some but not all cell lines. Of cell lines tested, lenalidomide was effective in inhibiting growth of Namalwa cells (a human B cell lymphoma cell line with a deletion of one chromosome 5) but was much less effective in inhibiting growth of KG-1 cells (human myeloblastic cell line, also with a deletion of one chromosome 5) and other cell lines without chromosome 5 deletions. Lenalidomide inhibited the growth of multiple myeloma cells from patients, as well as MM.1S cells (a human multiple myeloma cell line), by inducing cell cycle arrest and apoptosis.It is indicated for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
3s corporation is Supplier, Exporter , Wholesaler for Lenalidomide Capsules 5, 10, 15 & 25 mg in India.
We even offer contract manufacturing services from WHO GMP approved factories.
ADDITIONAL INFORMATION
lenalidomide is an analogue of thalidomide. thalidomide is a known human teratogen that causes severe life-threatening human birth defects. If lenalidomide is taken during pregnancy, it may cause birth defects or death to an unborn baby. females should be advised to avoid pregnancy while taking lenalidomide.
SIDE EFFECTS
The most frequently reported adverse events were related to blood and lymphatic system disorders, skin and subcutaneous tissue disorders, gastrointestinal disorders, and general disorders and administrative site conditions.
Thrombocytopenia and neutropenia are the most frequently reported adverse events observed. The next most common adverse events observed are diarrhea , pruritus, rash and fatigue.
Manufacturer: Natco Pharma Ltd
Other Brand Name: Temodal, Temodar
Temonat also known as Temodar or Temodal belongs to the general group of medicines known as antineoplastics. It is used to treat specific types of cancer of the brain in adults whose tumors have returned and whose tumors have just been diagnosed.
The dosage of Temozolomide prescribed to each patient will vary. Always follow your physician’s instructions and/or the directions on the prescription drug label.
Temozolomide can cause side effects such as nausea, vomiting, constipation, tiredness, loss of appetite, headache, and fever.
Packing 100 mg capsules of 5 capsules
DESCRIPTION
Temonat is used to treat certain types of brain cancer. It is a chemotherapy drug that works by slowing cancer cell growth. In some patients, temozolomide decreases the size of brain tumors. How to use Temozolomide Oral Read the Patient Information Leaflet provided by your pharmacist before you start using temozolomide and each time you get a refill. If you have any questions about the information or if you are not certain which days of the treatment cycle to take your medication, consult your doctor or pharmacist.
Take this medication by mouth, usually once daily or as directed by your doctor. To reduce nausea and vomiting, take it on an empty stomach (1 hour before or 3 hours after a meal) or at bedtime, unless otherwise directed by your doctor. To make sure the amount of medicine in your body is kept at a constant level, take it at the same time every day in relation to a meal (e.g., always 1 hour before the evening meal or always 3 hours after the evening meal). Swallow the capsules whole with a full glass of water (8 ounces or 240 milliliters). The dosage is based on your medical condition, body size, and response to therapy.
Do not crush, chew, or open the capsules. If the capsules are accidentally opened or damaged, avoid inhaling the medication, and do not let it touch the skin or mucous membranes (e.g., inside the nose). If contact occurs, flush the area with water. Since this drug can be absorbed through the skin, women who are pregnant or who may become pregnant should not handle this medication. Do not increase your dose or take this medication more often without your doctor’s approval. Your condition will not improve any faster and the risk of serious side effects may be increased. What conditions does this medication treat? Temozolomide Oral is used to treat the following: A Type of Brain Cancer – Anaplastic Astrocytoma, Malignant
Veenat is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), leukemias and other cancers. Cancers are characterized by uncontrolled growth of cells, and leukemia is a specific type of cancer characterized by uncontrolled proliferation of white blood cells
SIDE EFFECTS
Veenat may decrease the effectiveness of levothyroxine.
Side effects
the side effects associated with veenat are fluid retention, anxiety, bone pain, constipation, cough, diarrhea, dizziness, gas, hair loss, headache, increased tear production, loss of appetite, muscle cramps, muscle or joint pain, nausea, night sweats, nose and throat irritation, abdominal pain, hemorrsion problems, and yellowing of the eyes or skin.
Note:
Veenat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Aprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy, including high-dose cisplatin.
Aprepitant is for the treatment of adult patients with chemotherapy induced nausea and vomiting.
ADDITIONAL INFORMATION
Aprepitant is given for 3 days as part of a regimen that includes a corticosteroid and a 5-HT3 antagonist. The recommended dose of Aprepitant is 125 mg orally 1 hour prior to chemotherapy treatment (Day 1) and 80 mg once daily in the morning on Days 2 and 3.
SIDE EFFECTS
Call your doctor at once if you have a serious side effect such as:
Less serious side effects may include:
Orlistat blocks absorption of dietary fat into the bloodstream, thereby reducing the number of calories you get from a meal. At the usual dosage level, it cuts fat absorption by almost one-third. Combined with a low-calorie diet, it is used to promote weight loss and discourage the return of unwanted pounds. It is also known as Xenical in many countries.
The drug is prescribed for the frankly obese and for merely overweight people who have other health problems such as high blood pressure, diabetes, or high cholesterol levels. Your weight status is determined by your body mass index (BMI), a comparison of height to weight.-
Most important fact about this drug
Along with dietary fat, Orlistat decreases the absorption of some fat-soluble vitamins and beta-carotene. To compensate, you should take a multivitamin containing vitamins A, E, D, and K once a day, at least 2 hours before or 2 hours after taking Xenical.
ADDITIONAL INFORMATION
How should you take this medication:Take a capsule of Orlistat during, or up to 1 hour after, each main meal. You should follow a nutritionally balanced, low-calorie diet that provides no more than 30 percent of its calories from fat. If you miss a meal, or the meal contains no fat, you can skip the accompanying dose of Xenical.
If you miss a dose:Resume taking Orlistat at the next meal. Don’t try to make up the loss with a double dose. The extra drug won’t help.
Storage instructions:Store at room temperature, in a tightly sealed container.
SIDE EFFECTS
Side effects of Orlistat are more common during the first year of treatment. If any develop or change in intensity, inform your doctor as soon as possible. Only your doctor can determine if it is safe for you to continue taking Xenical.
More common side effects may include:Abdominal discomfort or pain, anxiety, arthritis, back pain, diarrhea, dizziness, earache, fatigue, fatty or oily stools, fecal urgency or incontinence, flu, gas with fecal discharge, gum problems, headache, increased defecation, menstrual problems, muscle pain, nausea, oily discharge, rectal discomfort or pain, respiratory tract infections, skin rash, sleep problems, tooth problems, urinary tract infections, vaginal inflammation, vomiting
Less common side effects may include:Dry skin, ear/nose/throat problems, joint disordersSide effects that usually occur after the first year of treatment with Orlistat include: depression, leg pain, swollen feet, and tendonitis.——————————————————————————–
Why should this drug not be prescribed?Do not take Orlistat if you suffer from “chronic malabsorption syndrome”–a condition that prevents nutrients from passing from your stomach into your bloodstream–or from cholestasis, a blockage in the supply of bile needed for digestion. You’ll also need to avoid Orlistat if it gives you an allergic reaction.——————————————————————————–
Special warnings about this medicationWeight loss begins within 2 weeks and continues for 6 to 12 months. The effect of using Orlistat for more than 2 years is still unknown.
Side effects such as diarrhea and abdominal pain may be worse if you continue eating a high fat diet or even take a high-fat meal. Limit your fat intake.
Your doctor will test your thyroid function before starting you on Orlistat to make sure that your weight problem is not due to an underactive thyroid gland (hypothyroidism). Orlistat is not an appropriate remedy for this problem.
Orlistat increases the likelihood of kidney stones. Use it with caution if you have a history of this problem.
If you have diabetes, weight-loss is likely to reduce your blood sugar levels. If you’re taking an oral diabetes medication or insulin, your dose may have to be reduced.
Note that the safety and efficacy of this drug in children have not been established.
Trientine 250 mg (Trientine Hydrochloride) is a white to pale yellow crystalline hygroscopic powder containing active ingredients Trientine hydrochloride which is a chelating compound for removal of excess copper from the body. Trientine is indicated in the treatment of patients with Wilson’s disease who are intolerant of penicillamine.
Dosage :
Recommended initial dose of SYPRINE is 500-750 mg/day for pediatric patients and 750-1250 mg/day for adults given in divided doses two, three or four times daily. This may be increased to a maximum of 2000 mg/day for adults or 1500 mg/day for pediatric patients age 12 or under.
The daily dose of SYPRINE should be increased only when the clinical response is not adequate or the concentration of free serum copper is persistently above 20 mcg/dL. Optimal long-term maintenance dosage should be determined at 6-12 month intervals
SIDE EFFECTS
Possible side effects may be hives, difficulty breathing, swelling of your face, lips, tongue, or throat, cough, trouble breathing; pale skin, easy bruising or bleeding, weakness, tired feeling, muscle or joint pain, swollen glands, seizure (convulsions) muscle weakness, dropping eyelids, double vision, or problems with speech, balance, walking, lifting, chewing, or swallowing
Ursofalk ( ursodeoxycholic acid ) contains bile acid, which may have a protective effect on the liver by reducing the absorption of other potentially toxic bile salts. Ursofalk is used to treat liver diseases such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and cystic fibrosis (CF)-related cholestasis.
Dosage : During the first 3 months of treatment, you should take Ursofalk Capsules in the morning, at midday and in the evening. As liver function values improve, the total daily dose may be taken once a day in the evening.
Most common side effects are Diarrhoea , Itching/pruritus, Urticaria (nettle rash), Allergic reactions, Nausea/vomiting, Sleep disturbance, Pain in the stomach area or in the upper right part of the belly, under the ribs.
Vingraf (Tacrolimus) is an immunosuppressant used for organ transplantation. It can be obtained only with prescription.
Dosage :
KIDNEY TRANSPLANT:
LIVER TRANSPLANT:
HEART TRANSPLANT:
Initial dose: 0.0375 mg/kg orally every 12 hours. Initiate no sooner than 6 hours after surgery
SIDE EFFECTS
Most common side effects are Headache, Nausea, Insomnia (difficulty in sleeping), Diarrhoea, Renal dysfunction, Increased glucose level in blood, Tremor.
Biomus (Tacrolimus) is a prescription drug used for organ transplantation. It is an immunosuppressant which suppresses body’s immune system ad thereby prevents rejection of transplanted organ.
Dosage :
Dose for Atopic Dermatitis :
Apply a thin layer to the affected areas 2 times a day and rub in gently and completely; discontinue use when symptoms resolve
SIDE EFFECTS
Common side effects are Headache, Nausea, Insomnia (difficulty in sleeping), Diarrhoea, Renal dysfunction, Increased glucose level in blood, Tremor.
Get in touch with us for obtain Suninat 50 Capsules. The capsules are sourced from known vendors of the market. One can obtain these at reasonable rates from us.
Description :
Addiitional Information :
Side Effect :
Hansepran (Clofazimine ) 100mg Capsule is used in the treatment of leprosy. It works by inhibiting the growth of bacteria in the body.
Dosage
Hansepran should be taken with meals.
Hansepran should be used preferably in combination with one or more other antileprosy agents to prevent the emergence of drug resistance.
For the treatment of proven dapsone-resistant leprosy, Hansepran should be given at a dosage of 100 mg daily in combination with one or more other antileprosy drugs for 3 years, followed by monotherapy with 100 mg of Hansepran daily. Clinical improvement usually can be detected between the first and third months of treatment and is usually clearly evident by the sixth month.
For dapsone-sensitive multibacillary leprosy, a combination therapy with two other antileprosy drugs is recommended. The triple-drug regimen should be given for at least 2 years and continued, if possible, until negative skin smears are obtained. At this time, monotherapy with an appropriate antileprosy drug can be instituted.
The treatment of erythema nodosum leprosum reactions depends on the severity of symptoms. In general, the basic antileprosy treatment should be continued, and if nerve injury or skin ulceration is threatened, corticosteroids should be given. Where prolonged corticosteroid therapy becomes necessary, Hansepran administered at dosages of 100 to 200 mg daily for up to 3 months may be useful in eliminating or reducing corticosteroid requirements. Dosages above 200 mg daily are not recommended, and the dosage should be tapered to 100 mg daily as quickly as possible after the reactive episode is controlled. The patient must remain under medical surveillance.
SIDE EFFECTS
Most common side effects are Vomiting, Nausea, Diarrhoea, Loss of appetite, Rash, Itching, Scaling of skin, Skin discolouration, Eye discolouration.
Our company is engaged in offering Thalide Capsules. These are formulated in compliance with international medical standards. We have all the in-house facilities to deliver bulk orders of these within the allocated timeframe.
Description :
Erythema Nodosum Leprosum :
Side effects include :
Other serious side effects include :
Orlistat 120 mg Capsules promotes weight loss and discourage the return of unwanted pounds. Our company is a distinguished Supplier and Exporter of Orlistat 120 mg Capsules from Maharashtra. Orlistat 120 mg Capsules blocks absorption of dietary fat into the bloodstream, thereby reducing the number of calories you get from a meal. At the usual dosage level, it cuts fat absorption by almost one-third. The Orlistat 120 mg Capsules are prescribed for obese and overweight people who have other health problems such as high blood pressure, diabetes, or high cholesterol levels.
How should you take this medication : Take a capsule of Orlistat during, or up to 1 hour after, each main meal. You should follow a nutritionally balanced, low-calorie diet that provides no more than 30 percent of its calories from fat. If you miss a meal, or the meal contains no fat, you can skip the accompanying dose of Xenical.
If you miss a dose : Resume taking Orlistat at the next meal. Don’t try to make up the loss with a double dose. The extra drug won’t help.
Storage instructions : Store at room temperature, in a tightly sealed container.
Side effects of Orlistat are more common during the first year of treatment. If any develop or change in intensity, inform your doctor as soon as possible. Only your doctor can determine if it is safe for you to continue taking Xenical.
More common side effects may include :Abdominal discomfort or pain, anxiety, arthritis, back pain, diarrhea, dizziness, earache, fatigue, fatty or oily stools, fecal urgency or incontinence, flu, gas with fecal discharge, gum problems, headache, increased defecation, menstrual problems, muscle pain, nausea, oily discharge, rectal discomfort or pain, respiratory tract infections, skin rash, sleep problems, tooth problems, urinary tract infections, vaginal inflammation, vomiting
Less common side effects may include :Dry skin, ear/nose/throat problems, joint disordersSide effects that usually occur after the first year of treatment with Orlistat include: depression, leg pain, swollen feet, and tendonitis.
Why should this drug not be prescribed ?Do not take Orlistat if you suffer from “chronic malabsorption syndrome”–a condition that prevents nutrients from passing from your stomach into your bloodstream–or from cholestasis, a blockage in the supply of bile needed for digestion. You’ll also need to avoid Orlistat if it gives you an allergic reaction.
Special warnings about this medication :Weight loss begins within 2 weeks and continues for 6 to 12 months. The effect of using Orlistat for more than 2 years is still unknown.
Side effects such as diarrhea and abdominal pain may be worse if you continue eating a high fat diet or even take a high-fat meal. Limit your fat intake.
Your doctor will test your thyroid function before starting you on Orlistat to make sure that your weight problem is not due to an underactive thyroid gland (hypothyroidism). Orlistat is not an appropriate remedy for this problem.
Orlistat increases the likelihood of kidney stones. Use it with caution if you have a history of this problem.
If you have diabetes, weight-loss is likely to reduce your blood sugar levels. If you’re taking an oral diabetes medication or insulin, your dose may have to be reduced.
Note : That the safety and efficacy of this drug in children have not been established.
Lenalid - Lenalidomide Capsules belong to a class of medicines called immunomodulatory agents. These capsules help in strengthening the immune responses in order to prevent inflammation in the body. Our Lenalid - Lenalidomide Capsules are precisely formulated and appreciated for their effective results. We provide these Lenalid - Lenalidomide Capsules in safe blister packing.
We are providing highly effective Lenalid 10 mg Capsules that belong to the class of medicines called immunomodulatory agents. Lenalid 10 mg Capsules help in strengthening the immune responses in order to prevent inflammation in the body. These Lenalid 10 mg Capsules are accredited for precise composition and fast & effective results owing to which these are highly recommended by the renowned medical practitioners.
Cometriq (cabozantinib) is a prescription medicine used to treat people with medullary thyroid cancer (MTC) which has spread to other parts of the body (called metastatic MTC).
Manufacturer : Exelixis, Inc.
ADDITIONAL INFORMATIONStrengths available : 100mg & 140mg
Form : Capsules
FDA Approved : US FDA Approved
Date of Approval : November 29th, 2012
Storage : Store at room temperature between 20° C – 25° C
Dosage :
Recommended Dose-
Do NOT substitute COMETRIQ capsules with cabozantinib tablets.
The recommended daily dose of COMETRIQ is 140 mg (one 80-mg and three 20-mg capsules). Do not administer COMETRIQ with food. Instruct patients not to eat for at least 2 hours before and at least 1 hour after taking COMETRIQ. Continue treatment until disease progression or unacceptable toxicity occurs.
Swallow COMETRIQ capsules whole. Do not open COMETRIQ capsules.
Do not take a missed dose within 12 hours of the next dose.
Do not ingest foods (e.g., grapefruit, grapefruit juice) or nutritional supplements that are known to inhibit cytochrome P450 while taking COMETRIQ.
Etoposide is a semisynthetic derivative of podophyllotoxin used in the treatment of certain neoplastic diseases. Etoposide Capsules USP 50 mg are indicated in the management of Small Cell Lung Cancer and Pancreatic cancer.
3s corporation is Supplier, Exporter , Wholesaler for Etoposide Capsules USP 50 mg in India.
India has many manufacturers who manufacture Etoposide Capsules USP 50 mg .
ADDITIONAL INFORMATION
Etoposide Capsules must be stored under refrigeration 2° to 8°C (36° to 46°F). The capsules are stable for 36 months under such refrigeration conditions.
SIDE EFFECTS
Myelosuppression is dose related and dose limiting, with granulocyte nadirs occurring 7 to 14 days after drug administration and platelet nadirs occurring 9 to 16 days after drug administration. Bone marrow recovery is usually complete by day 20, and no cumulative toxicity has been reported. Fever and infection have also been reported in patients with neutropenia. Death associated with myelosuppression has been reported.
The occurrence of acute leukemia with or without a preleukemic phase has been reported rarely in patients treated with etoposide in association with other antineoplastic agents .
Nausea and vomiting are the major gastrointestinal toxicities. The severity of such nausea and vomiting is generally mild to moderate with treatment discontinuation required in 1% of patients. Nausea and vomiting can usually be controlled with standard antiemetic therapy. Mild to severe mucositis/esophagitis may occur. Gastrointestinal toxicities are slightly more frequent after oral administration than after intravenous infusion.
Anaphylactic-like reactions characterized by chills, fever, tachycardia, bronchospasm, dyspnea and/or hypotension have been reported to occur in 0.7% to 2% of patients receiving intravenous etoposide and in less than 1% of the patients treated with the oral capsules. These reactions have usually responded promptly to the cessation of the infusion and administration of pressor agents, corticosteroids, antihistamines or volume expanders as appropriate; however, the reactions can be fatal. Hypertension and/or flushing have also been reported. Blood pressure usually normalizes within a few hours after cessation of the infusion. Anaphylactic-like reactions have occurred during the initial infusion of etoposide.
Facial/tongue swelling, coughing, diaphoresis, cyanosis, tightness in throat, laryngospasm, back pain and/or loss of consciousness have sometimes occurred in association with the above reactions. In addition, an apparent hypersensitivity-associated apnea has been reported rarely.
Rash, urticaria, and/or pruritus have infrequently been reported at recommended doses. At investigational doses, a generalized pruritic erythematous maculopapular rash, consistent with perivasculitis, has been reported.
Reversible alopecia, sometimes progressing to total baldness, was observed in up to 66% of patients.
The following adverse reactions have been infrequently reported: abdominal pain, aftertaste, constipation, dysphagia, asthenia, fatigue, malaise, somnolence, transient cortical blindness, optic neuritis, interstitial pneumonitis/pulmonary fibrosis, fever, seizure (occasionally associated with allergic reactions), Stevens-Johnson Syndrome, and toxic epidermal necrolysis, pigmentation, and a single report of radiation recall dermatitis.
Hepatic toxicity, generally in patients receiving higher doses of the drug than those recommended, has been reported with etoposide. Metabolic acidosis has also been reported in patients receiving higher doses.
Hydroxyurea Capsules USP 500 mg is an antineoplastic agent, Significant tumor response to hydroxyurea capsules, USP has been demonstrated in melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary.Hydroxyurea used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip.
3s corporation is Supplier, Exporter , Wholesaler for Hydroxyurea Capsules USP 500 mg in India.
India has many manufacturers who manufacture Hydroxyurea Capsules USP 500 mg.
ADDITIONAL INFORMATION
To minimize the risk of dermal exposure, always wear impervious gloves when handling bottles containing HYDROXYUREA capsules. HYDROXYUREA capsules should not be opened. Personnel should avoid exposure to crushed or opened capsules. If contact with crushed or opened capsules occurs, wash immediately and thoroughly.
SIDE EFFECTS
Call your doctor at once if you have a serious side effect such as: